Literature DB >> 577181

Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.

P Lund-Johansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 577181      PMCID: PMC1429025          DOI: 10.1111/j.1365-2125.1977.tb00685.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  A three-phase clinical evaluation of prazosin.

Authors:  I S Smith; M Fernandes; K E Kim; C Swartz; G Onesti
Journal:  Postgrad Med       Date:  1975-11       Impact factor: 3.840

2.  Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Acta Med Scand       Date:  1976

4.  Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.

Authors:  P Lund-Johansen
Journal:  Acta Med Scand       Date:  1974 Jan-Feb

5.  Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.

Authors:  R R Miller; L A Vismara; D T Mason
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

6.  Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

  6 in total
  5 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Hemodynamic effects of antihypertensive agents.

Authors:  P Lund-Johansen
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

4.  Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.

Authors:  P Lund-Johansen; O M Bakke
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

Review 5.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.